Dr. Daniel Bouland Appointed Chief of the Division of Hospital Medicine

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

Wolfgang Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

The Department of Medicine is very pleased to announce the appointment of Dr. Daniel Bouland as chief of the Division of Hospital Medicine effective July 1, 2016. Dr. Bouland will work with the Chair of Medicine and the CEO of the Health System to ensure continued growth of the division; additionally, Dr. Bouland will also continue to support the department of medicine in a new role as Vice Chair for Clinical Quality Improvement and Patient Experience.

Dr. Daniel L. Bouland

Daniel L. Bouland, MD, MS, FACP

Dr. Bouland is highly regarded as a clinician and educator as well as being an experienced leader in health care management and administration with vast experience in the field of hospital medicine across various governmental and private sectors.

Dr. Bouland received his medical training at Loma Linda University School of Medicine and completed an internal medicine residency at the same institution, serving an additional year as chief medical resident at affiliated Riverside General Hospital/University Medical Center (RGH/UMC). Commitments with the United States Public Health Service afforded Dan opportunities to work with indigent populations in southern California as well as the Indian Health Service. Upon his subsequent return to RGH/UMC, Dr. Bouland was progressively appointed Assistant, Associate, and then Chair of the Department of Medicine. During this time, additional functions included vice-chair of the Department of Medicine and Associate Program Director, Internal Medicine Residency Program, Loma Linda University Medical Center; president of hospital-based physicians RGH/UMC; and CEO/President of the Mission Medical Group of the Inland Empire. Of note internationally, in addition to lectures and clinical care, is his establishing and maintaining a US-style medicine residency program at Sir Run Run Shaw Hospital, Zhejiang Medical University in Hangzhou, China.

In 2000, Dan moved to Hawaii to serve as Associate Chief of Staff for Primary Care and Medicine of the Veterans Affairs Pacific Islands Health Care System (VAPIHCS), and then as Director of the Office of Referral and Management Services of the VAPIHC.

After joining the UCSD Division of Hospital Medicine in 2006, Dan completed a Master’s program in Health Care Management at Harvard. He has taken on many leadership roles within the University, including serving as Vice Chair for Clinical Operations in the department of medicine and as Director of Evaluation for the Altman Clinical and Translational Research Institute.

Current research efforts focus primarily on Quality Improvement initiatives, particularly the application of a results-oriented, business management approach to health care.

Please join me in congratulating Dr. Bouland in his formal appointment as Chief of the Division of Hospital Medicine.

Drs. John Chang, William Sandborn and Kim Barrett Honored by American Gastroenterological Association at DDW 2016

Drs. John T. Chang, William J. Sandborn and Kim E. Barrett have received high honors at Digestive Diseases Week® 2016, the annual joint meeting of the American Gastroenterological Association and other gastroenterology and hepatology societies.

John T. Chang, MD

John T. Chang, MD

John T. Chang, MD, Associate Professor of Medicine in the Division of Gastroenterology, was honored with the AGA Young Investigator Award in Basic Science.  |  Read AGA Press Release

The award recognizes Dr. Chang for his originality and innovative insight into basic mechanisms underlying lymphocyte fate specification in systemic and mucosal immune responses.

Dr. Chang is currently exploring whether pharmacologic modulation of proteasome activity might be a useful strategy for improving memory cell generation, highly relevant for mucosal vaccine development.  |  Visit the Chang Laboratory

Dr. William Sandborn

William J. Sandborn, MD

William J. Sandborn, MD, AGAF, received the 2016 AGA Institute Council Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award.

Dr. Sandborn is Professor of Medicine and Chief of the Division of Gastroenterology at UC San Diego.

The AGA Institute Council Intestinal Disorders Section Research Mentor Award went to Kim E. Barrett, PhD, AGAF, Professor of Medicine in the Division of Gastroenterology and Dean of Graduate Studies at UC San Diego.

Kim E. Barrett, PhD

Kim E. Barrett, PhD

The AGA gave its highest honor, the Julius Friedenwald Award, to C. Richard Boland, MD, AGAF, a past leader of the UC San Diego Division of Gastroenterology.

Dr. Boland was Chief of Gastroenterology at UC San Diego from 1995 to 2003.  |  Read the AGA Press Release

Dr. Boland, now at the Baylor University Medical Center in Dallas, TX, received the award for his lifelong contributions to the field of gastroenterology and the AGA.

The American Association for the Study of Liver Diseases (AASLD), American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT) are other sponsoring societies in DDW.

A Triple Play for Gastroenterology at UC San Diego

Division of Gastroenterology physician-scientists John T. Chang, MD, Pradipta Ghosh, MD, and Bernd Schnabl, MD, all were inducted into the American Society for Clinical Investigation on April 15, 2016.

To become a member of the ASCI, one of North America’s oldest and most respected medical honor societies, outstanding young investigators must be nominated and their nominations reviewed, ranked and scored in a process that selects less than 80 scientists from all areas of medicine each year.

“To have three young investigators from a single institution receive this honor in a single year is remarkable,” said William Sandborn, MD, Professor of Medicine and Chief of the Division of Gastroenterology.

Said Sheila E. Crowe, MD, Director of Research in Gastroenterology, “This is indeed an exceptional achievement for John, Pradipta and Bernd as individuals, and they bring great honor to the Division collectively.”

The three honorees are Associate Professors of Medicine in the Division of Gastroenterology.

Chang-John_120x150

John T. Chang, MD

John T. Chang, MD, investigates fundamental mechanisms underlying lymphocyte fate specification in systemic and mucosal immune responses. This research theme has important relevance to human health and disease, particularly vaccine design for infectious diseases that affect the gastrointestinal tract and in developing new therapeutic approaches for inflammatory bowel disease.

Dr. Chang is principal investigator of several active research grants, including two NIH R01 grants, an NIH Director’s New Innovator Award, and a Crohn’s & Colitis Foundation of America Senior Research Award. These grants fund Dr. Chang’s research to elucidate mechanisms by which regulators of polarity and asymmetric division influence T lymphocyte fate specification and function during microbial infection; the process by which T lymphocytes develop into pathogenic cells that cause intestinal inflammation; and identifying new approaches that enhance the function of regulatory T cells for the treatment of inflammatory bowel disease.

He is also a past recipient of a Howard Hughes Medical Institute Physician-Scientist Early Career Award and a V Foundation V Scholar Award. The latter has supported his work on the role of the cellular degradation machinery in cancer stem cell homeostasis.

Dr. Chang earned his MD from Temple University. He took two years off during medical school as a Howard Hughes Medical Institute-National Institutes of Health Research Scholar to pursue research training. Dr. Chang completed his internship/residency and gastroenterology fellowship training, along with four years of postdoctoral research in immunology, at the University of Pennsylvania. He joined the UC San Diego Division of Gastroenterology faculty in 2009.

Dr. Pradipta Ghosh

Pradipta Ghosh, MD

Pradipta Ghosh, MD, investigates the cell biology of signal transduction to find new ways to understand and block the development and spread of cancer and other diseases. Dr. Ghosh’s work has established a new paradigm in signal transduction by characterizing a new family of proteins which allow diverse receptors to transactivate heterotrimeric G-proteins. She unraveled the molecular mechanisms that govern such activation and established its unique spatiotemporal features. Finally, she demonstrated the relevance of this paradigm to modern medicine by defining the therapeutic potential of key signaling interfaces in diverse pathophysiologic states including diabetes, organ fibrosis, and cancer.

Her research funding includes three NIH R01 research grants, among them two five-year National Cancer Institute research grants that support her projects, “Modulation of G Proteins by Growth Factors” and “Spatial Regulation of G Protein Signaling.”

Among her scholarly awards are an American Gastroenterology Association Research Scholar Award in 2008, a Burroughs Wellcome Fund Career Award for Medical Scientists in 2009, and a Doris Duke Charitable Foundation (DDCF) Clinical Scientist Development Award in 2010.

Dr. Ghosh joined the Division of Gastroenterology faculty as assistant professor of medicine in 2008. She is a graduate of the UC San Diego Internal Medicine Residency Training Program, the Gastroenterology Fellowship Training Program and the Department of Medicine Physician-Scientist Training Program. She earned her MBBS in medicine at Christian Medical College and Hospital, India.

Bernd Schnabl, MD, PhD

Bernd Schnabl, MD

Bernd Schnabl, MD, focuses his research on liver disease. In studies funded by an NIH R01 grant, a NIH U01 cooperative agreement, a VA Merit Award, and industry grants, he is examining the relationship between liver disease and the intestinal microbiota.

He seeks to understand mechanisms by which the intestinal microbiome, metagenome and metabolome promote the development of chronic liver diseases. The goals of his investigations include the identification of new therapeutic targets for patients with liver disease.

Dr. Schnabl’s past honors and awards include an NIH K08 Career Development Award from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases and an American Gastroenterological Association/Astra Zeneca Faculty Transition Award. The K08 award supported his project, “Blocking Toll-Like Receptor 4 Signaling as Therapy in Hepatic Fibrosis.” He is currently Associate Editor of Digestive Disease and Sciences, the oldest continuously published gastroenterology journal in North America.

After he received his medical degree from the University of Freiburg in Germany, Dr. Schnabl spent three years in postdoctoral research at the University of North Carolina at Chapel Hill. He completed his medical residency at the University Hospital in Regensburg/Germany and his gastroenterology fellowship training at Columbia University College of Physicians and Surgeons in New York City.

He joined the UC San Diego Division of Gastroenterology in 2008.

The ASCI new member induction ceremony took place on Friday, April 15, at the 2016 Joint Meeting of the Association of American Physicians, the ASCI, and the American Physician-Scientists Association in Chicago.

No. 1 From the Start

UC San Diego Bioengineering ranked first by National Research Council since founding 50 years ago —

Bioengineers at UC San Diego have helped us understand why atherosclerosis develops and how it is impacted by blood flow. They have pioneered the development of very thin, small and flexible sensors that stick to the skin and monitor vital signs, such as the brain activity of a newborn. They also developed injectable hydrogels that can help muscle tissues heal after a heart attack.

Researchers celebrated their achievements over the past five decades and looked to the future during a three-day 50th anniversary celebration May 19 to 21. … Read the Full Story from the UC San Diego Newsroom


Shu Chien, PhD

Shu Chien, PhD

The founding chair of the UC San Diego Department of Bioengineering is Shu Chien, PhD, Distinguished Professor of Medicine in the Division of Physiology and Professor of Bioengineering. He is founding director of the UC San Diego Institute of Engineering in Medicine.

Dr. Chien is an elected Fellow of the National Academy of Inventors and the American Association for the Advancement of Science, among many honorific societies, and he received the Franklin Institute Award in November 2015.

Dr. Catriona Jamieson Receives Excellence in Stewardship Award

Catriona H. M. Jamieson, MD, PhD

Catriona Jamieson, MD, PhD

Dr. Catriona Jamieson is one of three UC San Diego faculty and staff members to receive an Excellence in Stewardship Award this year.

In his announcement to the campus community on April 21, Chancellor Pradeep K. Khosla said, “The UC San Diego community defines exemplary stewardship as taking every measure to ensure that our supporters – donors, volunteers, corporate partners and foundations – understand the full impact and importance of their involvement with UC San Diego.

“Excellent stewardship goes beyond saying ‘thank you’ and instills pride and further engagement by fully communicating to supporters all that their engagement has made possible.”

Catriona Jamieson, MD, PhD, is Associate Professor of Medicine, Chief of the Division of Regenerative Medicine, Deputy Director of the Sanford Stem Cell Clinical Center, Co-Leader of the Hematologic Malignancies Program and Director of the Moores Cancer Center Stem Cell Research Program.

She and the other honorees will be recognized at the annual UC San Diego Foundation Dinner on June 2, 2016. The award is presented by the Trustees of the UC San Diego Foundation Board.

More information is available on the UC San Diego Excellence in Stewardship website.

Dr. Kim Kerr Named Attending Physician of the Year at UC San Diego Health

Dr. Kim KerrDr. Kim Kerr, Clinical Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine and Medical Director of the Thornton Intensive Care Unit, has been selected as the Attending Physician of the Year for 2015-2016 at UC San Diego Health.

On National Doctors Day each year, UC San Diego Health honors its physicians for their commitment and service in health care. The Attending Physician of the Year award recognizes an attending faculty member for particular excellence in the many facets of patient care and clinical teaching.

Kim M. Kerr, MD, attends on the pulmonary thromboendarterectomy (PTE), ICU and pulmonary consult services. Her chief clinical and research interests are in chronic thromboembolic pulmonary hypertension and critical care.

Dr. Kerr has been named on the San Diego’s Top Doctors list every year for the past seven years.

Four Department of Medicine Faculty Members Are on 2015 Thomson Reuters Highly Cited Researchers List

Dr. William Sandborn

William Sandborn, MD

Four UC San Diego Department of Medicine researchers are among the most influential researchers in the world, according to the 2015 Thomson Reuters Highly Cited Researchers list.

They are , William Sandborn, MDDon W. Cleveland, PhD, Lewis J. Rubin, MD, and Sergei L. Kosakovsky Pond, PhD.

Dr. Don W. Cleveland

Don W. Cleveland, PhD

Dr. Sandborn is Professor and Chief of the Division of Gastroenterology & Hepatology.

Dr. Cleveland is Chair of the Department of Cellular and Molecular Medicine and Distinguished Professor of Medicine, Cellular and Molecular Medicine, and Neurosciences.

Sergei L. Kosakovsky Pond, PhD

Sergei L. Kosakovsky Pond, PhD

Dr. Pond, Associate Professor of Medicine, is a specialist in infectious disease with a focus on developing software models of evolving pathogens such as HIV and hepatitis C virus.

Dr. Rubin, whose research addresses pulmonary vascular disease and pulmonary arterial hypertension, is Professor of Medicine, Emeritus, in the Division of Pulmonary, Critical Care & Sleep Medicine.

Lewis Rubin, MD

Lewis Rubin, MD

With 165 faculty members on the latest edition of the list, the UC System ranks first in the world on the list of highly cited researchers.

Each year, Thomson Reuters uses citation analysis to identify the world’s most influential contemporary scientists. The 2015 list, encompassing publications from 2003 to 2013, contains more than 3,100 names.

More on the UC System’s achievement from the UC Office of the President

See the names of all UC System faculty members on the list

More about the list and the methodology from Thomson Reuters

View a searchable database of the researchers

Distinguished Professor Shu Chien Elected Fellow of National Academy of Inventors

December 15, 2015

Two researchers at the University of California, San Diego, have been named fellows of the National Academy of Inventors.

Shu Chien, Distinguished Professor of Bioengineering and Medicine, and Michael Sailor, Distinguished Professor of Chemistry and Biochemistry, were among 168 new fellows announced by the academy today.. … Read the full story from the UC San Diego Newsroom


Shu Chien, MD, PhD

Shu Chien, MD, PhD. Photo courtesy of Jacobs School of Engineering/UC San Diego.

Shu Chien, MD, PhD, is a world-renowned researcher and inventor who has conducted pioneering investigations in atherosclerosis and hypertension. His work has brought about significant advances in the diagnosis and treatment of cardiovascular disease.

Dr. Chien is founding chair of the UC San Diego Department of Bioengineering and director of the Institute of Engineering in Medicine. In the Department of Medicine, he is Distinguished Professor of Medicine in the Division of Physiology.

Earlier in 2015, Dr. Chen was selected to receive the prestigious Franklin Institute Award and was elected a fellow of the American Association for the Advancement of Science.

Drs. Shu Chien and Stephen Howell Named AAAS Fellows

December 1, 2015

Department of Medicine professors Shu Chien, MD, PhD, and Stephen Howell, MD, have been named fellows of the American Association for the Advancement of Science, the largest scientific society in the world. … Read the full story from the UC San Diego Newsroom

Professor Shu Chien Receives Prestigious Franklin Institute Award

November 16, 2015

Philadelphia, Nov. 12, 2015 – Shu Chien, founding chair of the Department of Bioengineering at the University of California, where is he currently a professor and director of the Institute of Engineering in Medicine, has received the prestigious Franklin Institute Award.

The award is conferred by the Philadelphia-based Franklin Institute. It has gone in previous years to an extraordinary list of great men and women who have significantly improved our world with their pioneering innovations, including Thomas Edison, Marie Curie, Stephen Hawking, Jacques Cousteau, and more recently Jane Goodall, Dean Kamen and Bill Gates. … Read the full press release from the Jacobs School of Engineering


Shu Chien, MD, PhD

Shu Chien, MD, PhD. Photo courtesy of Jacobs School of Engineering/UC San Diego.

In addition to his leadership roles in the Department of Bioengineering and the Institute of Engineering in MedicineShu Chien, MD, PhD, is a Professor of Medicine in the Division of Physiology.

In a recent major development in his scientific explorations, Dr. Chien is one of four principal investigators in the organizational hub of the $30 million 4D Nucleome Research Centers and Organizational Hub grant the National Institutes of Health awarded to UC San Diego in October.

The goal of the project is to determine how DNA is arranged within the cell’s nucleus in four dimensions (three-dimensional space plus time) and how changes in that nuclear organization affect human health and disease.

More information about Dr. Chien and his work: